ORTEXORTEX News
Tracking CVBF? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CV
Trader NoteCVBF

CVBF heads into earnings with shorts rebuilding and options traders turning bullish

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 21:20

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

CVB Financial Corp. reports Q3 results on October 22 with an unusual combination: short interest climbing back toward recent highs just as options traders shift to their most bullish posture in weeks.

Short positions have been rebuilding steadily since early October. Short interest has risen roughly 4.5% on the week to 7.3% of the free float, around 9.97 million shares. That follows a sharp reversal from the September 30 peak, when short interest briefly touched roughly 14.7 million shares before unwinding almost as fast as it arrived. The current level sits comfortably below that spike, but the week-on-week and month-on-month drift higher (up about 8.6% over the past 30 days) suggests bears have been rebuilding rather than retreating. Borrowing remains cheap at 0.44%, down roughly 18% on the week, and availability is wide at nearly 800% of short interest, meaning there is no friction for new shorts to enter. The borrow market is loose, not stressed.

Options traders are telling a different story. The put/call ratio has dropped to 0.22, nearly two standard deviations below its 20-day average of 0.23, making this one of the most call-heavy readings in recent months. That gap between rising short interest and falling put demand is the tension worth watching: either shorts are wrong-footed heading into the print, or call buyers are taking a pre-earnings flier that unwinds quickly. The 52-week put/call range runs from 0.20 to over 12, so the absolute level is not extreme, but the directional move into results day is striking.

The Street leaning is cautiously constructive. Analysts raised targets across the board after the July quarter, with Piper Sandler moving to $28 (Overweight), Evercore ISI lifting to $26 (Outperform), and Raymond James upgrading to Outperform in July. Those moves came after Q2 core EPS of $0.43 beat expectations, and a net interest margin of 3.70% held up better than feared. The mean target of around $26.17 implies roughly 18% above the current $22.16. Bears point to the California commercial real estate concentration, roughly 77% of loans tied to CRE, and the risk that margin compression and sluggish loan demand eat into earnings power if rates stay elevated. On valuation, the stock trades at 11.4 times earnings and 1.14 times book, both modest multiples for a regional bank. The EPS forward revision score ranks in the 99th percentile of the universe, a standout, though near-term EPS surprise has been more mixed at the 12th percentile.

FDIC call report data through June show total assets and total deposits each hit their largest second-quarter levels on record since 2024, at $21.2 billion and $16.4 billion respectively. The FDIC series has not yet been tested as a lead indicator against CVBF's reported figures, so those records are company context rather than a signal about the October print. Separately, retail attention has spiked sharply, with the Wikipedia and ORTEX page-view composite z-score hitting 5.7 as of October 19, well above the stock's own 90-day baseline, consistent with earnings preview activity.

Insider flows over the past 90 days net to a modest negative: the Chief Accounting Officer filed a small tax-withholding transaction on October 20 (359 shares, classified as a non-market-sale under code F). The two noteworthy open-market moves earlier in the period were director Mike Maddox buying 10,000 shares at $22.03 in late August and director Raymond O'Brien buying 20,000 shares at $22.77 in late July. The COO sold 40,000 shares at $22.94 in August, a larger trade that offsets those purchases in net terms. None of these trades were made under a pre-arranged 10b5-1 plan. The pattern is mixed rather than directional: insiders have bought near current levels but one sizeable sale keeps the 90-day net slightly negative.

The last two quarterly prints saw the stock rise roughly 1.4% the day after results and hold those gains through the five-day window, a benign reaction history. Close peers HOPE and UBSI both gained around 2 to 3% on the week, tracking roughly in line with CVBF's own 3.2% weekly gain, so there is no meaningful relative divergence to read into.

The October 22 print is therefore less about whether CVBF is growing and more about whether the NIM can hold above 3.70%, what the next instalment on CRE credit quality looks like, and whether management gives any guidance on the 15-million-share buyback pace given the 16.3% CET1 buffer.

Stocks in this article

See the live data behind this article on ORTEX.

Open CVBF on ORTEX →

How this article was generated

Generated
21 Oct 2026, 21:23
Data as of
21 Oct 2026, 21:20
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.